Aurora Cannabis says Curaleaf plans unsolicited bid valuing shares at US$4 each
Reuters2026/08/13 15:42- Curaleaf outlined plans for an unsolicited bid for Aurora Cannabis at implied consideration of USD 4 per share.
- Terms include 0.3463 Curaleaf subordinate voting shares, USD 0.75 cash per Aurora share, capped at USD 5.
- Curaleaf sent proposals on June 23, 2026, then July 7, 2026; only the latter included financial terms.
- Aurora’s board plans to form a special committee of independent directors to evaluate the proposal.
- No decision has been made; the company continues executing its strategy, including the recently completed Safari Flower acquisition.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas
A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260

10-Yr Benchmark Govt Yields - Germany vs Other Nations